Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-003856
Filing Date
2018-04-02
Accepted
2018-04-02 15:56:31
Documents
1
Period of Report
2018-03-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4032918mazur_citiuspharma.html 4  
1 OWNERSHIP DOCUMENT f4032918mazur_citiuspharma.xml 4 24678
  Complete submission text file 0001213900-18-003856.txt   26288
Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 11 COMMERCE DRIVE, 1ST FLOOR CRANFORD NJ 07016
Business Address
Mazur Leonard L (Reporting) CIK: 0001463414 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38174 | Film No.: 18728790

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Issuer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations